Overview of the Grant Opportunity
The Gates Foundation is inviting applications for a significant grant aimed at reducing the burden of preeclampsia, a serious condition affecting pregnant women. The application period opens on February 11, 2025, and the deadline for submission is March 25, 2025, at 11:30 AM Pacific Time. This grant provides an opportunity for interested organizations to contribute to vital research and therapeutics targeting preeclampsia.
Understanding Preeclampsia
Preeclampsia is a placental disease that poses severe risks during pregnancy, leading to complications such as maternal morbidity and mortality. It arises due to two primary pathologies: early-onset disease linked to decreased uteroplacental blood flow, and late-onset disease due to increased fetoplacental demands. Both forms converge on elevated levels of the protein sflt1, indicating the necessity for innovative therapeutic strategies.
Eligibility and Application Details
Organizations eligible to apply for this grant include nonprofits, for-profit companies, academic institutions, and government agencies, particularly those that are women-led or based in low- and middle-income countries. Projects can receive up to $500,000 USD, with a grant term of up to two years. Applicants should ensure that their budget aligns with the project scope, adhering to the Gates Foundation’s indirect cost policy.
For comprehensive information and to submit your application, please visit the reducing the burden of preeclampsia challenge page. If you have inquiries regarding your application, contact grandchallenges@gatesfoundation.org.